The role of cytological examination in the detection of lung tumors

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background: Lung cancer is a widespread group of tumor lesions characterized by late detection and high mortality rates, which determines the need for its effective diagnosis. Cytological examination is the primary link in the morphological verification of lung cancer, has a number of advantages and has high diagnostic indicators.

Aim: To evaluate the diagnostic potential of cytological examination in the detection of lung tumor lesions using samples of material obtained by various methods.

Materials and methods: A retrospective assessment of traditional cytological samples of lung material taken by various methods from 301 patients who were hospitalized and examined in 2018–2023 was carried out. The cytological picture was categorized using the terminological assessment system in respiratory cytopathology (World Health Organization, 2022) and the international reporting system for cytopathology of serous fluids in 2016. The diagnostic parameters of the method of cytological diagnosis of lung cancer were evaluated according to the following criteria: diagnostic sensitivity, diagnostic specificity, diagnostic effectiveness.

Results: The most common types of lung cancer in the study group were: squamous cell carcinoma — 123 cases (41.6% of the total number of primary and secondary lung cancer), adenocarcinoma — 94 (31.8%), small cell lung cancer — 29 (9.8%), carcinoid — 11 (3.7%). Cytological changes were categorized in accordance with international reporting systems, and the detectability of tumor changes was analyzed based on material obtained by various methods. Additionally, a correlation was made between the detected cytomorphological features in the most common forms of primary lung cancer in the study group and the literature data.

Conclusion: Without taking into account the material with the lowest diagnostic indicators, the diagnostic potential of cytological diagnosis in the detection of lung cancer was as follows: sensitivity — 87.6%, specificity — 98.6%, diagnostic effectiveness — 86.4%. The cytological diagnosis of brush biopsies, fine needle aspiration biopsy material, and prints from the biopsy and lung tissue has high diagnostic parameters, which determines the possibility of prioritizing the use of these types of material for primary morphological verification of lung cancer.

Full Text

Restricted Access

About the authors

Andrey A. Kireev

Russian Medical Academy of Continuous Professional Education; Moscow City Hospital named after S.S. Yudin

Author for correspondence.
Email: aa.kireev@bk.ru
ORCID iD: 0000-0002-1366-7504
SPIN-code: 9035-6812

MD, Cand. Sci. (Medicine)

Russian Federation, Moscow; Moscow

Irina P. Shabalova

Russian Medical Academy of Continuous Professional Education

Email: irenshab@inbox.ru
ORCID iD: 0000-0002-7838-6279
SPIN-code: 7390-0085

MD, Dr. Sci. (Medicine)

Russian Federation, Moscow

References

  1. Kaprin AD, Starinsky VV, Shakhzadova AO, editors. The state of cancer care for the Russian population in 2020. Moscow: P.A. Herzen Moscow Institute of Medical Sciences − branch of the Federal State Budgetary Institution “ NMIC of Radiology ” of the Ministry of Health Russia; 2021. (In Russ.)
  2. Inage T, Nakajima T, Yoshino I, Yasufuku K. Early Lung Cancer Detection. Clinics in Chest Medicine. 2018;39(1):45–55. doi: 10.1016/j.ccm.2017.10.003
  3. Blandin Knight PA, Crosbie H, Balata J, et al. Progress and prospects of early detection in lung cancer. Open Biology. 2017;7(9):170070. doi: 10.1098/rsob.170070
  4. de Sousa VML, Carvalho L. Heterogeneity in Lung Cancer. Pathobiology. 2018;85(1–2):96–107. doi: 10.1159/000487440
  5. Schwartz AG, Cote ML. Epidemiology of Lung Cancer. Advances in experimental medicine and biology. 2016;893:21–41. doi: 10.1007/978-3-319-24223-1_2
  6. Savostikova MV, Fedoseeva ES, Furminskaya EYu. Modern cytomorphological diagnosis of lung tumors. Russian News of Clinical Cytology. 2018;3–4(22):3–7. (In Russ.) EDN: NMLKAU
  7. Grigoruk OG, Pupkova EE, Bazulina LM, Lazarev AF. The usage of cytological material for diagnostics of lung cancer. Malignant tumors. 2017;7(4):13–20. doi: 10.18027//2224-5057-2017-7-4-13-20
  8. Mino-Kenudson M. Cytological reporting on lung FNA and small biopsy specimens in the era of personalized medicine. Cancer Cytopathology. 2017;125(3):155–160. doi: 10.1002/cncy.21793
  9. Chrabańska M, Środa M, Kiczmer P, et al. Lung Cancer Cytology: Can Any of the Cytological Methods Replace Histopathology? Journal of Cytology. 2020;37(3):117–121. doi: 10.4103/JOC.JOC_168_19
  10. Layfield LJ, Esebua M. A modified Papanicolaou Society of Cytopathology system for reporting respiratory cytology specimens: Implications for estimates of malignancy risk and diagnostic accuracy. Diagnostic Cytopathology. 2021;49(11);1167–1172. doi: 10.1002/dc.24840
  11. Travis WD. Lung Cancer Pathology: Current Concepts. Clinics in Chest Medicine. 2020;41(1):67–85. doi: 10.1016/j.ccm.2019.11.001
  12. Kireev AА. Cytomorphological patterns of lung cancer. Russian News of Clinical Cytology. 2024;28(1):27–34. doi: 10.24412/1562-4943-2024-1-0005
  13. Schreiber G, McCrory DC. Performance Characteristics of Different Modalities for Diagnosis of Suspected Lung Cancer*. Chest. 2003;123(1):115S–128S. doi: 10.1378/chest.123.1_suppl.115s
  14. Truong LD, Underwood RD, Greenberg SD, McLarty JW. Diagnosis and typing of lung carcinomas by cytopathologic methods. A review of 108 cases. Acta Cytologica. 1985;29:379–384.
  15. Meyer KC. Bronchoalveolar Lavage as a Diagnostic Tool. Seminars in Respiratory and Critical Care Medicine. 2007;28(5):546–560. doi: 10.1055/s-2007-991527
  16. Tomar V, Vijay N, Nuwal P, Dixit R. Comparative study of bronchoalveolar lavage, bronchial brushing, and FNAC in diagnosing malignant neoplasms of lungs. Journal of Cytology. 2016;33(4):210–213. doi: 10.4103/0970-9371.190448
  17. Shapiro NA. Cytological diagnosis of lung diseases: color atlas. Moscow: Reprocenter; 2005. (In Russ.) EDN: QLKHPZ

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2024 Kireev A.A., Shabalova I.P.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ:  ПИ № ФС 77 - 86785 от 05.02.2024 (ранее — ПИ № ФС 77 - 59057 от 22.08.2014).